… meta-analysis provides evidence that rituximab therapy reduces the frequency of NMOSD
… However, the safety profile suggests caution in prescribing rituximab as a first-line therapy. …

… rituximab, is an alternative therapy for relapsing and refractory systemic lupus erythematosus.
We sought to assess the long-term efficacy and safety of rituximab in this patient subgroup. …

… Thus, to evaluate safety and efficacy of RTX in off-trial SLE patients, we analyzed prospective
data on 136 SLE patients included in the French AutoImmunity and Rituximab (AIR) registry…

… rituximab and consequently opportunistic infections rarely occur in association with rituximab
therapy… event during rituximab therapy or within the first 30 days following therapy. However…

… Our aim was to assess the efficacy and safety of RTX as well as its influence on QoL when
used in different immunologic diseases. Since we wanted to give an overview including also …

… The aim of the systematic review was to evaluate the safety and efficacy of rituximab for the
treatment of rheumatoid arthritis patients, as part of the Consensus on the use of rituximab in …

… The last important issue is the best therapeutic rituximab regimen for ITP. The standard “…
Some groups from the United Kingdom and Italy reported the efficacy and safety of rituximab …

… In order to recommend rituximab, it would be useful to identify a profile of patients who are
… the efficacy and the safety of rituximab in the treatment of non-renal manifestations of SLE. …

… This systematic review summarizes the efficacy and safety of rituximab for the treatment
of adults with ITP. Rituximab resulted in complete response (platelet count > 150 × 10 9 cells/L) …

… after the rituximab therapy, so our finding that rituximab is … have reported the therapeutic
efficacy of rituximab in patients … showed that a single rituximab injection reduced the number of …